-
Thematic Analysis
Digital Marketing Trends in Inflammatory Bowel Disease
Digital Marketing Trends in Inflammatory Bowel Disease Report Overview AbbVie’s Skyrizi.com achieved the highest total traffic across inflammatory bowel disease (IBD) patient sites in the US, with over 9.3 million visitors from March 2022 to February 2023. This was followed by AbbVie’s Rinvoq.com and Takeda’s Entyvio.com. The highest proportion of traffic originated from direct sources, followed by organic. Xeljanz.com was supported by the most paid search engine optimization (SEO) while Takeda spent on digital display advertising (DDA) for Entyvio.com. The digital marketing...
-
Thematic Analysis
Digital Marketing Trends in Rheumatoid Arthritis
Digital Marketing Trends in Rheumatoid Arthritis Report Overview AbbVie’s Rinvoq.com achieved the highest total traffic across rheumatoid arthritis (RA) patient brand sites in the US, with over four million visitors from February 2022 to January 2023. This was followed by AbbVie’s Humira.com and Amgen’s Enbrel.com. The highest proportion of traffic to branded patient RA websites originated from organic sources, followed by direct. Xeljanz.com was supported by the most paid search engine optimization (SEO) while Amgen spent the most on digital display advertising (DDA)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HCP-1803
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry HCP-1803 Drug Details HCP-1803 is under development for the treatment of essential hypertension. It...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HCP-2102
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry HCP-2102 Drug Details HCP-2102 is under development for the treatment of essential hypertension. Report...
-
Thematic Analysis
Digital Marketing Trends in Breast Cancer
Between November 2021 and October 2022, Merck & Co’s Keytruda.com achieved the highest traffic among branded breast cancer patient sites in the US. This was followed by Eli Lilly’s Verzenio.com. The highest proportion of traffic to branded sites originated from direct sources, followed by organic sources. The digital marketing trends in the breast cancer report will help to understand the digital marketing competitive landscape in BC, with a view of leading patient and HCP branded assets across different regions. The...
-
Product Insights
Peptic Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Peptic Ulcers are open sores that develop on the inside lining of the esophagus, stomach, and the upper portion of the small intestine. Symptoms include nausea or vomiting, unexplained weight loss, appetite changes, and abdominal pain. Risk factors include smoking and alcoholism. Treatment includes antibiotics, acid blockers, antacids, and proton pump inhibitors. The Peptic Ulcers pipeline drugs market research report provides comprehensive information on the therapeutics under development for Peptic Ulcers, complete with analysis by stage of development, drug target,...
-
Report Bundle
58% offTech in Pharma – Report Bundle (7 Reports)
Tech in Pharma Bundle Report Overview Although the pharmaceutical industry had been slow to adopt technological innovations, the onset of COVID-19 has dramatically altered the situation. The latest technologies, Augmented Reality (AR), Big Data, and Artificial Intelligence (AI), among others, will assist pharmaceutical companies in speeding up the research and development process, creating personalized products, and conducting testing in novel ways. Finally, these technologies will improve healthcare effectiveness and efficiency thereby transforming the patient and provider experience. Explore actionable market...
-
Product Insights
Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Specific Proteins are reagents and test kits that are used to quantify and detect protein molecules from bodily fluids. The Specific Proteins pipeline market research report provides comprehensive information about the Specific Proteins pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Thematic Analysis
Digital Marketing Trends in Hepatocellular Carcinoma
Merck & Co.’s Keytruda com achieved the highest traffic across US hepatocellular carcinoma (HCC) patient sites, with 2.1 million visits from August 2021 to July 2022. This was followed by Bristol Myers Squibb's  (BMS) Opdivo.com (1.2 million visits) and Genentech's Tecentriq com (497,000 visits). The highest proportion of traffic to these sites originated from direct sources, followed by organic and referral traffic. The digital marketing trends in hepatocellular carcinoma research report will help to understand the digital marketing competitive landscape...
-
Thematic Analysis
Digital Marketing Trends in Migraine
Digital Marketing Trends in Migraine Report Overview Biohaven’s Nurtec.com achieved the highest traffic across branded migraine patient sites in the US from July 2021 to June 2022, followed by Eli Lilly’s Emgality.com and Allergan’s Botoxchronicmigraine.com. The highest proportion of traffic to these sites originated from direct sources, followed by referrals and organic traffic. Websites for several brands, including Emgality, Vyepti, Botox, and Nurtec, had similar levels of high direct traffic, while Amgen’s Aimovig.com had the lowest. Most branded websites in...